Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA inspection of Dr Reddy's Mexican facility could start to clear import block

This article was originally published in Scrip

Executive Summary

Dr Reddy's Mexican facility, which has been under the scanner for current good manufacturing practice deviations, is expected to be inspected by the US FDA sometime next week. The move is seen as part of significant steps towards resolving GMP concerns surrounding the unit after the FDA issued an import alert for certain products manufactured there in June last year.

Topics

Related Companies

UsernamePublicRestriction

Register

SC016681

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel